Related Experiment Videos
[Effects of disopyramide on normal and pathological atrioventricular conduction]
1Service de Cardiologie, Centre Hospitalier Général, Aix-en-Provence.
Annales De Cardiologie Et D'Angeiologie
|October 1, 1992
Summary
Disopyramide, a class Ia antiarrhythmic, has anticholinergic effects that influence cardiac conduction. It can depress conduction in rapid-response cells but improve it in others, showing a complex electrophysiological profile.
Area of Science:
- Pharmacology
- Cardiac Electrophysiology
Context:
- Disopyramide is a Vaughan-Williams class Ia antiarrhythmic drug.
- Its anticholinergic activity stems from its metabolite, mono-N-alkyl disopyramide.
- It exhibits differential effects on cardiac conduction based on cell response type.
Purpose:
- To elucidate the electrophysiological mechanisms of disopyramide.
- To evaluate its effects on cardiac conduction in various cardiac tissues.
- To assess its clinical implications for arrhythmias and conduction disorders.
Summary:
- Disopyramide depresses conduction in rapid-response cells (His-Purkinje) but has opposing effects in slow-response cells (nodes) due to direct depression and anticholinergic stimulation.
- Clinically, it's a Touboul class IIa compound, prolonging His-Purkinje conduction and refractory times.
- Studies show improved nodal conduction and a depressant effect on automatism, counteracted by vagolytic effects at the atrioventricular node.
Impact:
- Disopyramide demonstrates safety and potential improvement in nodal conduction disorders and non-major intraventricular conduction problems like bundle branch block.
- It is particularly indicated for junctional tachycardia involving accessory pathways and effective in intranodal tachycardia.
- These findings support the use of disopyramide in patients with moderate nodal conduction issues and simple bundle branch block.